Phase 2 Randomised, Double-blind, Placebo-controlled, Cross-over Study for the Assessment of Glucose Metabolism Changes With RVX000222 in Individuals With Pre-diabetes
Phase of Trial: Phase II
Latest Information Update: 01 Jun 2016
At a glance
- Drugs Apabetalone (Primary)
- Indications Prediabetic-state
- Focus Therapeutic Use
- Sponsors Resverlogix Corporation
- 08 Jun 2015 As per a Resverlogix Corporation media release, results of this study were presented at the 75th scientific sessions of American Diabetic Association 2015.
- 31 Mar 2014 Trial status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 31 Mar 2014 The treatment phase of the trial has been completed according to a Resverlogix media release.